These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

343 related articles for article (PubMed ID: 12494405)

  • 1. Regional differences in sympathetic purinergic transmission along the length of the mouse vas deferens.
    Knight D; D'Arbe M; Liang S; Phillips WD; Lavidis NA
    Synapse; 2003 Mar; 47(3):225-35. PubMed ID: 12494405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of fast purinergic transmission in the mouse vas deferens.
    Liang SX; D'arbe M; Phillips WD; Lavidis NA
    Synapse; 2000 Sep; 37(4):283-91. PubMed ID: 10891865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postnatal androgen deprivation dissociates the development of smooth muscle innervation from functional neurotransmission in mouse vas deferens.
    Brock JA; Handelsman DJ; Keast JR
    J Physiol; 2007 Jun; 581(Pt 2):665-78. PubMed ID: 17379637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of 7-nitro indazole on neurotransmission in the rat vas deferens: mechanisms unrelated to inhibition of nitric oxide synthase.
    Allawi HS; Wallace P; Pitcher A; Gaffen Z; Bland-Ward PA; Moore PK
    Br J Pharmacol; 1994 Sep; 113(1):282-8. PubMed ID: 7529112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Spatial distribution and developmental appearance of postjunctional P2X1 receptors on smooth muscle cells of the mouse vas deferens.
    Liang SX; Motin L; Moussa CE; Lavidis NA; Phillips WD
    Synapse; 2001 Oct; 42(1):1-11. PubMed ID: 11668586
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The purinergic component of human vas deferens contraction.
    Banks FC; Knight GE; Calvert RC; Thompson CS; Morgan RJ; Burnstock G
    Fertil Steril; 2006 Apr; 85(4):932-9. PubMed ID: 16580377
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The mechanism of action of AMP-induced inhibition of sympathetic neurotransmission in the isolated vas deferens of the rat and guinea-pig.
    Dalziel HH; Sneddon P
    Br J Pharmacol; 1988 Jul; 94(3):961-7. PubMed ID: 2846112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the differential release of the cotransmitters ATP and noradrenaline from sympathetic nerves of the guinea-pig vas deferens.
    Todorov LD; Mihaylova-Todorova S; Craviso GL; Bjur RA; Westfall DP
    J Physiol; 1996 Nov; 496 ( Pt 3)(Pt 3):731-48. PubMed ID: 8930840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Actions of alpha, beta-methylene ATP and 6-hydroxydopamine on sympathetic neurotransmission in the vas deferens of the guinea-pig, rat and mouse: support for cotransmission.
    Allcorn RJ; Cunnane TC; Kirkpatrick K
    Br J Pharmacol; 1986 Dec; 89(4):647-59. PubMed ID: 3028548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens.
    Ellis JL; Burnstock G
    Br J Pharmacol; 1989 Aug; 97(4):1157-64. PubMed ID: 2551441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paired pulse analysis of ATP and noradrenaline release from sympathetic nerves of rat tail artery and mouse vas deferens: effects of K+ channel blockers.
    Msghina M; Gonon F; Stjärne L
    Br J Pharmacol; 1998 Dec; 125(8):1669-76. PubMed ID: 9886758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens.
    Sneddon P; Westfall TD; Todorov LD; Todorova SM; Westfall DP; Nickel P; Kennedy C
    Br J Pharmacol; 2000 Mar; 129(6):1089-94. PubMed ID: 10725256
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Noradrenergic, purinergic, and cholinergic transmission in the mouse vas deferens: influence of field-stimulation parameters, reserpinization, 6-hydroxydopamine and 4-aminopyridine.
    Kaschube M; Zetler G
    J Neural Transm; 1989; 76(1):39-53. PubMed ID: 2540260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelin modulation of neuroeffector transmission in rat and guinea pig vas deferens.
    Wiklund NP; Ohlén A; Wiklund CU; Hedqvist P; Gustafsson LE
    Eur J Pharmacol; 1990 Aug; 185(1):25-33. PubMed ID: 2171959
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Temperature-dependent contractions of the guinea pig vas deferens mediated by P2X receptors].
    Ziganshin AU; Ziganshina LE; Rychkov AV; Zaĭtsev AP; Falu ZhIu; Khaziakhmetov DF
    Eksp Klin Farmakol; 2001; 64(4):27-30. PubMed ID: 11589103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attenuation of contractility in rat epididymal vas deferens by Rho kinase inhibitors.
    Amobi NI; Chung IP; Smith IC
    Auton Autacoid Pharmacol; 2006 Apr; 26(2):169-81. PubMed ID: 16553645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermittent ATP release from nerve terminals elicits focal smooth muscle Ca2+ transients in mouse vas deferens.
    Brain KL; Jackson VM; Trout SJ; Cunnane TC
    J Physiol; 2002 Jun; 541(Pt 3):849-62. PubMed ID: 12068045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuropeptide Y neuromodulation of sympathetic co-transmission in the guinea-pig vas deferens.
    Ellis JL; Burnstock G
    Br J Pharmacol; 1990 Jul; 100(3):457-62. PubMed ID: 2167733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endothelin-induced facilitation of sympathetic neurotransmission to the rat vas deferens: effects of suramin.
    Lau WA; Ventura S; Jiang Q; Pennefather JN
    Eur J Pharmacol; 1995 Jan; 272(1):31-8. PubMed ID: 7536159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regional difference in sympathetic neurotransmitter- and Ca2+ channel-mediated responses in rat vas deferens.
    Matsuki N; Higo K; Saito H; Nakazawa K
    Gen Pharmacol; 1996 Jun; 27(4):689-93. PubMed ID: 8853306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.